Named as a key player in 66 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Point Of Care (PoC) Molecular Diagnostic | Healthcare Services | $18.7 Bn | 9.3% |
| Blood Plasma | Pharmaceuticals | – | – |
Named as key players in the same markets as Grifols (number of shared markets).
Biotest LLC1 shared market
Cepheid1 shared market
CSL Behring1 shared market
Danaher Corporation1 shared market
Hologic, Inc.1 shared market
Kedrion Biopharma1 shared market